Maxwell Biosciences
Austin
About Maxwell Biosciences
Maxwell Biosciences is a preclinical-stage drug platform company actively developing an entirely new CLAROMER biotechnology platform that creates low-molecular-weight compounds that mimic peptides and are functionally distinct from macromolecules due to their ease of penetrating membranes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $30.8M
- Last round: Undisclosed (Aug 2025)
- Website: maxwellbiosciences.com
- Phone: 855-629-2461
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/maxwell-biosciences-65671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.